A Potent (R)-alpha-bis-lipoyl Derivative Containing 8-Hydroxyquinoline Scaffold: Synthesis and Biological Evaluation of Its Neuroprotective Capabilities in SH-SY5Y Human Neuroblastoma Cells

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2013 Nov 27

PMID 24275787

Citations 7

Authors

Ivana Cacciatore

Erika Fornasari

Leonardo Baldassarre

Catia Cornacchia

Stefania Fulle

Ester Sara Di Filippo

Tiziana Pietrangelo

Francesco Pinnen

Affiliations

Soon will be listed here.

Abstract

A novel bis-lipoyl derivative containing 8-hydroxyquinoline scaffold (LA-HQ-LA, 5) was synthesized as a new multifunctional drug candidate with antioxidant, chelant, and neuroprotective properties for the treatment of neurodegenerative diseases. We have investigated the potential effectiveness of LA-HQ-LA against the cytotoxicity induced by 6-OHDA and H2O2 on human neuroblastoma SH-SY5Y cell line. Our outcomes showed that LA-HQ-LA resulted in significant neuroprotective and antioxidant effects against H2O2- and 6-OHDA-induced neurotoxicity in human neuroblastoma SH-SY5Y cells, as assessed by MTT assay. In particular, it showed potent neuroprotective effects against 6-OHDA in RA/PMA differentiated cells at all the tested concentrations.

Citing Articles

3-(1H-pyrazole-1-yl/1H-1,2,4-triazole-1-yl)-N-propananilide Derivatives: Design, Synthesis and Neuroprotectivity Potential Against 6-OHDA Induced Neurotoxicity Model.

Tarikogullari Dogan A, Saylam M, Yilmaz S, Parlar S, Ballar P, Alptuzun V Turk J Pharm Sci. 2025; 22(1):1-9.

PMID: 40052327 PMC: 11887587. DOI: 10.4274/tjps.galenos.2024.72365.

Products Derived from Leaves Have In Vitro Antioxidant Activity and Protect Larvae against -Induced Injury.

Silva T, Cavalcanti Filho J, Barreto Fonseca M, Santos N, Barbosa da Silva A, Zagmignan A Pharmaceuticals (Basel). 2020; 13(3).

PMID: 32188166 PMC: 7151707. DOI: 10.3390/ph13030046.

Syntheses, Crystal Structures, and Antitumor Activities of Copper(II) and Nickel(II) Complexes with 2-((2-(Pyridin-2-yl)hydrazono)methyl)quinolin-8-ol.

Yang Q, Cao Q, Qin Q, Deng C, Liang H, Chen Z Int J Mol Sci. 2018; 19(7).

PMID: 29949884 PMC: 6073241. DOI: 10.3390/ijms19071874.

Crystal structure of methyl ()-4-[2-(8-hy-droxy-quinolin-2-yl)vin-yl]benzoate.

Xu Y, Hu W, Zhao G Acta Crystallogr E Crystallogr Commun. 2016; 72(Pt 9):1251-1253.

PMID: 27920909 PMC: 5120699. DOI: 10.1107/S205698901601210X.

Effect of 8-hydroxyquinoline and derivatives on human neuroblastoma SH-SY5Y cells under high glucose.

Suwanjang W, Prachayasittikul S, Prachayasittikul V PeerJ. 2016; 4:e2389.

PMID: 27635352 PMC: 5012261. DOI: 10.7717/peerj.2389.

References

Presgraves S, Ahmed T, Borwege S, Joyce J . Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res. 2004; 5(8):579-98. DOI: 10.1007/BF03033178. View

Kayyali R, Pannala A, Khodr H, Hider R . Comparative radical scavenging ability of bidentate iron (III) chelators. Biochem Pharmacol. 1998; 55(8):1327-32. DOI: 10.1016/s0006-2952(97)00602-3. View

Minelli A, Conte C, Cacciatore I, Cornacchia C, Pinnen F . Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson's animal model. Amino Acids. 2012; 43(3):1359-67. DOI: 10.1007/s00726-011-1210-x. View

Lopes F, Londero G, de Medeiros L, Lisboa da Motta L, Behr G, de Oliveira V . Evaluation of the neurotoxic/neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6-hydroxydopamine. Neurotox Res. 2012; 22(2):138-49. DOI: 10.1007/s12640-012-9311-1. View

Mattson M . Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders. Ann N Y Acad Sci. 2004; 1012:37-50. DOI: 10.1196/annals.1306.004. View

LEPOIVRE M, Flaman J, Bobe P, Lemaire G, Henry Y . Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages. J Biol Chem. 1994; 269(34):21891-7. View

Pinnen F, Cacciatore I, Cornacchia C, Mollica A, Sozio P, Cerasa L . CNS delivery of L-dopa by a new hybrid glutathione-methionine peptidomimetic prodrug. Amino Acids. 2010; 42(1):261-9. DOI: 10.1007/s00726-010-0804-z. View

LeBel C, Ischiropoulos H, Bondy S . Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol. 1992; 5(2):227-31. DOI: 10.1021/tx00026a012. View

Di Vaira M, Bazzicalupi C, Orioli P, Messori L, Bruni B, Zatta P . Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes. Inorg Chem. 2004; 43(13):3795-7. DOI: 10.1021/ic0494051. View

10.

Lopes F, Schroder R, da Frota Jr M, Zanotto-Filho A, Muller C, Pires A . Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res. 2010; 1337:85-94. DOI: 10.1016/j.brainres.2010.03.102. View

11.

Bush A . Metals and neuroscience. Curr Opin Chem Biol. 2000; 4(2):184-91. DOI: 10.1016/s1367-5931(99)00073-3. View

12.

Cacciatore I, Cornacchia C, Baldassarre L, Fornasari E, Mollica A, Stefanucci A . GPE and GPE analogues as promising neuroprotective agents. Mini Rev Med Chem. 2011; 12(1):13-23. DOI: 10.2174/138955712798868995. View

13.

Jellinger K . General aspects of neurodegeneration. J Neural Transm Suppl. 2003; (65):101-44. DOI: 10.1007/978-3-7091-0643-3_7. View

14.

Tieu K, Zuo D, Yu P . Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins. J Neurosci Res. 1999; 58(3):426-35. View

15.

Ho R, Minturn J, Hishiki T, Zhao H, Wang Q, Cnaan A . Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor. Cancer Res. 2005; 65(21):9868-75. DOI: 10.1158/0008-5472.CAN-04-2426. View

16.

Cacciatore I, Cornacchia C, Pinnen F, Mollica A, Di Stefano A . Prodrug approach for increasing cellular glutathione levels. Molecules. 2010; 15(3):1242-64. PMC: 6257297. DOI: 10.3390/molecules15031242. View

17.

Cornacchia C, Cacciatore I, Baldassarre L, Mollica A, Feliciani F, Pinnen F . 2,5-diketopiperazines as neuroprotective agents. Mini Rev Med Chem. 2011; 12(1):2-12. DOI: 10.2174/138955712798868959. View

18.

Minelli A, Conte C, Prudenzi E, Cacciatore I, Cornacchia C, Taha E . N-acetyl-L-methionyl-L-Dopa-methyl ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity. Free Radic Biol Med. 2010; 49(1):31-9. DOI: 10.1016/j.freeradbiomed.2010.03.011. View

19.

Xie H, Hu L, Li G . SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin Med J (Engl). 2010; 123(8):1086-92. View

20.

Minelli A, Conte C, Grottelli S, Bellezza I, Cacciatore I, Bolanos J . Cyclo(His-Pro) promotes cytoprotection by activating Nrf2-mediated up-regulation of antioxidant defence. J Cell Mol Med. 2008; 13(6):1149-61. PMC: 4496110. DOI: 10.1111/j.1582-4934.2008.00326.x. View